Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The O-antigen polysaccharide is the outermost, highly variable component of the lipopolysaccharide (LPS) complex located on the surface of Salmonella enterica serovar Typhimurium. It consists of repeating oligosaccharide units—typically comprising D-galactose, L-rhamnose, and D-mannose with an abequose side chain—that determine the bacterium's O-serogroup identity (Raetz & Whitfield, 2002). Biologically, the O-antigen serves as a critical virulence factor by protecting the pathogen from host innate immune defenses, such as complement-mediated lysis and phagocytosis, and by providing resistance to environmental stressors like bile (Hajra et al., 2021). In the context of drug development, the O-antigen is a primary target for glycoconjugate vaccines and therapeutic monoclonal antibodies designed to combat non-typhoidal Salmonella (NTS) infections (Micoli et al., 2018). These therapeutic strategies aim to elicit high-affinity antibodies that promote opsonophagocytosis and bacterial killing. However, the structural diversity of O-antigens across different serovars remains a significant challenge for creating broad-spectrum protective interventions (MacLennan et al., 2014).
Induction of opsonophagocytic and bactericidal antibodies that facilitate bacterial clearance by the immune system; neutralization of bacterial attachment and colonization.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on O-antigen polysaccharide of Salmonella typhimurium lipopolysaccharide (O-antigen).